The agent satisfied the core task of explaining what Circumvent Pharmaceuticals does, who it serves, and how it differs—but discovered the site's navigation structure was broken (multiple links returned 404s), forcing reliance on the homepage text and external sources to fill gaps on pricing, funding, and competitive positioning.

• ›Homepage (step [1]) was the only accessible page on the target domain; navigation menu items ('About', 'Approach', 'Patients') displayed in step [5] all returned 404 errors in steps [6–8], blocking direct access to deeper content.
• ›Core positioning information (palmitoylome/synaptome insights, enzyme mimetic approach) came entirely from the homepage fetch; no subpage elaborated these differentiators.
• ›Pricing and funding data did not exist on the site—agent correctly identified this absence and sourced it from external databases (PitchBook, Crunchbase, search results in steps [10–11]), which was the only way to answer that part of the task.
• ›Agent's final response accurately distinguished between what the site published (mission, science, partnerships) and what it lacked (clinical trial status, competitive comparisons, investor details), avoiding false claims about missing content.
• ›Site was minimally navigable for this discovery task; the homepage provided sufficient overview to answer 'what they do' and 'how they're different,' but the broken navigation prevented corroboration or deeper exploration that would have strengthened answers on patient information and approach details.